Stockreport

Impax Labs gets final FDA approval for generic of Novartis' Focalin XR [Seeking Alpha]

IMPAX LABORATORIES  (IPXL) 
Last impax laboratories earnings: 3/1 07:00 am Check Earnings Report
PDF Impax Laboratories (NASDAQ: IPXL ) premarket after saying it received final FDA approval of its Abbreviated New Drug Application for a generic version of Nov [Read more]